ZAPOMERAN
UNII J9E7RSF8K3

Substance Identification & Data

This profile provides standardized clinical and technical data for Zapomeran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J9E7RSF8K3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2727965-96-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
J9E7RSF8K3
CAS Registry Number
2727965-96-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ZAPOMERAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C190459
National Cancer Institute reference terminology for clinical and research data.
INN ID
12516
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zapomeran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZAPOMERAN

Common Names & Synonyms

MRNA-2105
RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-AM)-CAPPED VENEZUELAN EQUINE ENCEPHALITIS VIRUS RNA-DEPENDENT RNA POLYMERASE CODON-OPTIMIZED TRANSGENE PLUS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE PRE-FUSION GLYCOPROTEIN (614-GLYCINE,682-GLYCINE,683-SERINE,685-SERINE,986-PROLINE,987-PROLINE) PRECURSOR-SPECIFYING PLUS 5'- AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER MRNA-2105), INNER SALT
SELF-REPLICATING MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING CODON-OPTIMISED VENEZUELAN EQUINE ENCEPHALITIS VIRUS (VEEV) RNA-DEPENDENT RNA POLYMERASE (VEEV PROTEINS NSP1, NSP2, NSP3 AND NSP4) AND A FULL-LENGTH CODON-OPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K986P AND V987P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2) SPIKE (S) GLYCOPROTEIN (DERIVED FROM GENBANK ID YP_009724390) CONTAINING FURIN CLEAVAGE-INACTIVATING MUTATIONS (R682G, R683S,R685S) PLUS AN ADDITIONAL MUTATION (D614G), FLANKED BY 5' AND 3' UNTRANSLATED REGIONS AND A 3' POLYADENYLATION (POLYA) TAIL AND GENERATION OF THE CAPPED S MRNA IS UNDER CONTROL OF A VEEV SUBGENOMIC PROMOTER.
ZAPOMERAN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus